Stay updated on Anifrolumab in Active Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Anifrolumab in Active Lupus Nephritis Clinical Trial page.

Latest updates to the Anifrolumab in Active Lupus Nephritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded 2026-02-05/06 entries for Study Status and Contacts/Locations, with Revision: v3.4.2. Removed the previously shown government funding status notice.SummaryDifference0.8%

- Check21 days agoChange DetectedA government funding lapse notice appears and the site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedThe History page now includes a glossary toggle and color-coded highlights for changes (green for additions and red for deletions). The footer notes have been updated to Revision: v3.4.0 with related display text.SummaryDifference0.6%

- Check42 days agoChange DetectedOn 2026-01-12, added Contacts/Locations and updated Study Status (Revision: v3.3.4); the prior revision v3.3.3 was deleted on 2025-12-18.SummaryDifference0.4%

- Check64 days agoChange DetectedRevision v3.3.3 (2025-12-18) adds Contacts/Locations, Outcome Measures, Study Description, and Study Status. Revision v3.3.2 (2025-11-04) removes HHS Vulnerability Disclosure.SummaryDifference0.6%

- Check85 days agoChange DetectedThe page shows a new site revision label 'Revision: v3.3.2', replacing the previous 'Revision: v3.3.1'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Anifrolumab in Active Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anifrolumab in Active Lupus Nephritis Clinical Trial page.